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Abstract
Background: Drug-drug interactions are frequently reported in the increasing amount of biomedical literature.
Information Extraction (IE) techniques have been devised as a useful instrument to manage this knowledge.
Nevertheless, IE at the sentence level has a limited effect because of the frequent references to previous entities in
the discourse, a phenomenon known as ‘anaphora’. DrugNerAR, a drug anaphora resolution system is presented to
address the problem of co-referring expressions in pharmacological literature. This development is part of a larger
and innovative study about automatic drug-drug interaction extraction.
Methods: The system uses a set of linguistic rules drawn by Centering Theory over the analysis provided by a
biomedical syntactic parser. Semantic information provided by the Unified Medical Language System (UMLS) is also
integrated in order to improve the recognition and the resolution of nominal drug anaphors. Besides, a corpus has
been developed in order to analyze the phenomena and evaluate the current approach. Each possible case of
anaphoric expression was looked into to determine the most effective way of resolution.
Results: An F-score of 0.76 in anaphora resolution was achieved, outperforming significantly the baseline by
almost 73%. This ad-hoc reference line was developed to check the results as there is no previous work on
anaphora resolution in pharmalogical documents. The obtained results resemble those found in related-semantic
domains.
Conclusions: The present approach shows very promising results in the challenge of accounting for anaphoric
expressions in pharmacological texts. DrugNerAr obtains similar results to other approaches dealing with anaphora
resolution in the biomedical domain, but, unlike these approaches, it focuses on documents reflecting drug
interactions. The Centering Theory has proved being effective at the selection of antecedents in anaphora
resolution. A key component in the success of this framework is the analysis provided by the MMTx program and
the DrugNer system that allows to deal with the complexity of the pharmacological language. It is expected that
the positive results of the resolver increases performance of our future drug-drug interaction extraction system.
Background
A drug-drug interaction occurs when one drug influ-
ences the level or activity of another drug. Drug-drug
interactions are common adverse drug reactions and
unfortunately they are a frequent cause of death in hos-
pitals [1]. Several published drug safety issues have
showed that adverse effects of drugs may be detected
too late, when millions of patients have already been
exposed [2]. Therefore, they have an important impact
on patient safety because they can be quite dangerous
and their relatively high incidence among certain popu-
lation groups such as geriatric or polydrug patients. In
addition, drug interactions account for 16.6% of adverse
drug reactions causing hospitalization [3], thus they are
a direct cause of the increase of health care costs.
There are different resources which describe informa-
tion about drug interactions (for example, DRUG-REAX
System or the drug interaction appendix of the British
National Formulary, but unfortunately there is a lack of
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tions across them [4], and they rarely include the whole
range of drug interactions reported in the medical litera-
ture [5]. Therefore, the development of automatic meth-
ods for collecting, maintaining and interpreting this
information is crucial to achieve a real improvement in
their early detection. Natural Language Processing can
provide an interesting way to reduce the time spent by
health care professionals on reviewing the literature.
This proposal is included in the broader context of an
automatic system to extract drug interactions from
pharmacological texts (see Figure 1). Drug-Drug Interac-
tion Extraction is a difficult task whose complexity
increases when one or both drugs involved in an inter-
action are expressed with an anaphoric expression, as
s h o w ni nt h ef o l l o w i n gt e x te x c e r p t st a k e nf r o mt h e
DrugBank database [6,7]:
1. Although beta-adrenergic blockers or calcium
channel blockers and digoxin may be useful in
combination to control atrial fibrillation, their addi-
tive effects on AV node conduction can result in
advanced or complete heart block.
2. In addition triamterene, metformin and amilor-
ide should be co-administered with care as they
might increase dofetilide levels.
Anaphora resolution is often a task required to
improve the results of automatic extraction systems.
Anaphoric relations can be found within the sentence
level or even among different senteces. Although
approaches to anaphora resolution in the literature vary
in the use of features and in the accounted scope
between the anaphoric expression and its antecedent,
they can be grouped into two major approaches:
1. Heuristic approaches that integrate different knowl-
edge sources like gender and number agreement, syn-
tactic patterns or semantic information to obtain a
plausible list of candidates [8-10]. The major draw-
back of these approaches is that it is very labor-inten-
sive and time-consuming to construct the domain
knowledge base necessary for resolving the anaphors.
2. Machine learning approaches compute the most
likely candidate based on previous examples. These
approaches can sort out the referred problem in
heuristic approaches, however it usually comes
across the data sparseness problem of language
modeling, so they require a large amount of data to
train [11,12].
In the biomedical domain, the lack of available cor-
pora motivated that early approaches were mostly based
Figure 1 Architecture for drug-drug interactions extraction This figure shows the pipeline architecture of our drug-drug interaction
prototype. Firstly, texts are processed by the MMTx program. This tool performs sentence splitting, tokenization, POS-tagging, chunking, and
linking of phrases with UMLS concepts. Then, the drugs found in such documents are classified into drug families by a set of nomenclature rules
(WHOINN affixes) recommended by the World Health Organization (WHO) International Nonproprietary Names (INNs) Program to identify and
classify pharmaceutical substances. Over this basis, anaphora resolution is carried out to account for both nominal phrases referring to drugs and
pronouns. Finally, the output of the previous modules is sent to the relation extraction module that exploits this information in order to account
for drug interactions in biomedical documents.
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a method for resolving anaphoric expressions for can-
didates taken from MedLine articles and abstracts. By
defining a different range of resolution scope for each
type of anaphoric expression, it uses different morpho-
logical, syntactic and semantic features such as number
or semantic type agreement (UMLS typing-based sys-
tem), longest common subsequence for similarity
among candidate antecedents and coercion-type
matching (most suitable agent / patient linguistic role
according to the verb) from the most frequent bio-
relevant verbs in Medline. Each possible antecedent of
a certain anaphora was given a different cumulative
score according to the significance of its linguistic fea-
tures and the one with the best salience measure was
chosen. General results are 73.8% F-score over a cor-
pus of 46 MedLine abstracts which were annotated by
a domain expert.
Lin et al. [14] also apply this scoring technique but
they restrict the types of nominal anaphoric expressions
to be taken into account, enrich the syntactic features
with new values and apply coercion-type matching as
before, using Genia corpus [15]. General results are 92%
F-score in pronominal anaphora and 78% in nominal
anaphora in 32 Medline abstracts (MedStract) [16]. This
approach is improved in [17] by using new resources
like WordNet or PubMed for finding semantic relation-
ships among concepts not found in UMLS. They extend
the MedStract corpus with 100 Medline abstracts
obtaining 87.43% F-score for pronominal anaphora and
80.61% for nominal anaphora.
Anaphora resolution applied to the field of protein
interactions can be found in [18], which presents an
anaphora resolution system integrated in a larger pro-
tein-protein interaction extraction study, so-called
BioAR. It identifies antecedents of pronouns by applying
patterns for parallelism and centering theory [19]. Nom-
inal phrase anaphors are identified according to the
most salient score, using similar features as in [13,20].
Experimental results are 75% precision and 56.3% recall
in pronoun resolution and 75% precision and 52.2% in
definite noun phrase resolution from 120 unseen bio-
logical interactions extracted by BiolE system [20].
Likewise, in [21] the impact of anaphora resolution on
the result of a protein interaction extraction system is
analyzed by using the Guitar system [22] over the 20
full texts and abstracts of the Medstract corpus and
three articles taken from the Journal of Biological
Chemistry. From the 402 protein-protein interactions in
the corpus, only 20 were conveyed by an anaphoric
expression. Results show 70% recall in anaphora resolu-
tion in abstracts and 52.65% in full texts. No data about
precision are available. Results suggest small improve-
ments in protein extraction.
Regarding machine learning approaches to anaphora
resolution in biomedical documents, Nguyen and Kim
[23] carries out a comparative study with three different
corpora: MUC and ACE, accounting for the news
domain, and Genia for bio-medical documents. They
build a machine learning-based pronoun resolver using
a Maximum Entropy ranker model that selects the most
likely antecedent candidatef r o mas e to fc a n d i d a t e sb y
using a huge set of linguistic features divided into base-
line attributes like pronoun type, number, gender, string,
distance, etc.(mostly used in other approaches) and
innovative features like grammatical roles, most seman-
tically appropriate candidate or context information
about the anaphoric pronoun. From the latter group,
those improving baseline for each of the corpus were
selected obtaining 79.55% (Genia), 64.61%(ACE), 60.42%
(MUC) in success rate.
Anaphoric expressions are resolved in [24] presenting
a semisupervised approach that makes use of rich
domain resources such as the FlyBase database.
N o m i n a lp h r a s e sa r ei d e n t i f i e db yt h eu s eo ft h e
domain-independent parser RASP [25]. The system
was evaluated against two hand-annotated full papers
containing 302 sentences and 314 anaphoric expres-
sions. It looks for the closest antecedent matching the
anaphoric expression according to a set of linguistic
features. System reaches 58.8% precision and 57.3%
recall. A summary of the main approaches of biomedi-
cal anaphora resolution can be found in Table 1. The
approach presented in this paper, DrugNerAR, works
on drug-drug interaction documents following an heur-
istic approach for anaphora resolution partially moti-
v a t e db yt h el a c ko fal a r g ea n n o t a t e dc o r p u si nt h i s
domain. The range and order in the anaphora-antece-
dent matching is adopted from the model of Centering
Theory [19]. Linguistic analysis is provided by the
MMTx tool as proposed by [26] in which we developed
an approach for anaphora resolution for drug-drug
interactions documents based on a scoring method
similar to other works in the biomedical domain
[13,14,18]. Results show how this new approach out-
performs [26] and offers an interesting possibility to be
developed for other sub-domains in biomedicine.
Methods
This section describes our approach for anaphora reso-
lution in Drug-Drug Interaction documents. Figure 1
shows the pipeline architecture of our drug-drug inter-
action prototype. Firstly, texts are processed by the
MMTx program. This tool performs sentence splitting,
tokenization, POS-tagging, chunking, and linking of
phrases with UMLS concepts. This way, MMTx allows
to recognize a variety of biomedical entities occurring in
texts. Then, drugs found in such documents are
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which is is based on a set of nomenclature rules recom-
mended by the World Health Organization (WHO)
International Nonproprietary Names (INNs) [28] Pro-
gram to identify and classify pharmaceutical substances.
Over this basis, anaphora resolution is carried out to
account for both nominal phrases referring to drugs and
pronouns. Finally, the output of the previous modules
will be sent to the relation extraction module that will
exploit this information in order to account for drug
interactions in biomedical documents.
Corpus for drug anaphora resolution
Two different stages have been distinguished in the
creation of this corpus: compilation and annotation.
Compiling and preprocessing the corpus
There is no corpus dedicated to the resolution of the
anaphoric expressions occurring in drug interaction
descriptions in pharmacological documents, so the first
challenge was to build a corpus for research purposes.
DrugBank is an annotated database with about 4900
drug entries. Each entry contains more than 100 data
fields that gather detailed chemical and pharmacological
information (type, category, brand names, chemical for-
mula, drug interactions, etc).
A collection of 49 unstructured and plain documents
was taken randomly from the field ‘interactions’ in the
DrugBank database. Documents have on average 40 sen-
tences and 716 words. Documents were downloaded by
using an automatic robot developed with the free tool
openKapow [29].
Each document was subsequently preprocessed by
MMTx and the DrugNer system. Figure 2 shows an
example of a preprocessed document. This example is
limited to one input sentence without including infor-
mation about tokenization. For each phrase, it is offered
i t st y p ea sw e l la st h eC U I ,t h en a m ea n dt h es e m a n t i c
types of the UMLS concepts provided by MMTx (just in
case, the text of the phrase were founded in the UMLS
Metathesaurus). Let us take as example the prepositional
phrase s28.p369 (‘with aprazolam’ ) which was mapped
to the UMLS concept ‘Alprazolam’ (CUI=‘C0002333’)
whose semantic types are ‘orch’ (Organic Chemical) and
‘phsu’ (Pharmacological Substances). Moreover, the affix
‘-azolam’ definited by WHOINN program allows to clas-
sify this phrase as a ‘Benzodiazepine derivative’.
Annotating the corpus
Anaphora is a linguistic device to refer to entities that
have come up in recent discourse (antecedents). There
are two kinds of anaphors prevalent in this kind of
literature:
￿ Pronominal anaphora. In this case an entity is
referred to by a pronoun: personal (it,they), reflexive
(itself,themselves), relative (which, that) and distribu-
tive (both, each, either and neither). Pronominal
f o r m si nf i r s ta n ds e c o n dp e r s o n( I, me, you, your
and who) were disregarded for not referring to
drugs.
￿ Nominal (phrase) anaphora. This is the case of an
entity being referred to by a nominal phrase. These
phrases consists of a definite article (the), possessive
(its, their), demonstrative (this, these, those), distribu-
tive (both, such, each, either, neither) followed by a
generic term for drugs (such as antibiotic, medicine,
medication, etc) or a drug property or effect, e.g.,
these anticoagulants, its pharmacological effects.
The corpus was annotated manually by a linguist with
the assistance of a pharmaceutical expert over the out-
put of MMTx and DrugNer. The example shown in
Figure 2 also contains a pronominal anaphoric expres-
sion (phrase s28.p378, ‘it’ ) whose antecedent is anno-
tated by the attribute ID-ANTENCENT. In this case, the
antecedent is the phrase s28.p371 (of fluvoxamine). The
corpus contains a total of 331 anaphoric expressions
(see tables 2 and 3). A more detailed description of the
corpus can be found in [26].
Table 1 Summary of the main approaches to biomedical anaphora resolution
Authors Approach Corpus Results
Castano et al. [13] Scoring method 46 medline abstract F=0.74
Lin et al. [14] Scoring method 32 MedLine abstract
(MedStract)
F=0.92 pronominal, F=0.78
nominal
Kim et al. [18] Centering theory for pronominal anaphors and scoring method for
nominal anaphors
120 biological interactions F=0.64 pronominal, F=0.59
nominal
Liang and Lin [17] Scoring method MedStract + 100 Med- Line
abstract
F=0.87 pronominal, F=0.80
nominal
Segura-Bedmar et
al., [26]
Scoring method and a set of semantic and morphological
restrictions
49 MedLine abstracts F=0.85 pronominal, F=0.50
nominal
Nguyen and Kim
[23]
Maximum Entropy ranker model Genia Success rate: 79.55%
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resolution
The anaphora resolution issue can be split into three
different phases: identification of anaphoric expressions,
determination of anaphor scope and selection of
antecedents.
Identification of anaphoric expressions
All pronouns referred to in table 2 for pronominal ana-
phora were selected. Moreover, the pleonastic-it expres-
sions were excluded by using the rules proposed in [14].
These rules were extended to recognize the negation
and modal verbs as possible arguments in this kind of
expressions (see Table 4).
Regarding nominal phrase anaphora, candidates were
selected if attached to a drug family (analgesics, anticoa-
gulants, etc) or to a generic term for drugs (such as
‘medicine’, ‘medication’ or ‘drug’). Candidates consisting
of specific terms for drugs like ‘aspirin’, ‘fluvoxamine’,
etc., were disregarded. To achieve this, our module uses
the concept unique identifier (CUI) provided by MMTx
to distinguish between generic and proper noun for
drugs.
Candidate anaphors consisting of a possessive article
were restricted by only selecting those phrases attached
to the semantic type ‘Qualitative Concept’ in UMLS,
that is, those accounting for drug properties or effects,
e.g., ‘its pharmacological effect’, ‘their anticoagulant
properties’.
Figure 2 Example of sentence processed by MMTx and DrugNer and annotated with anaphoric expressions This example contains a
pronominal anaphoric expression (phrase s28.p378, ‘it’ ) whose antecedent is annotated by the attribute ID-ANTENCENT. In this case, the
antecedent is the phrase s28.p371 (’of fluvoxamine’ ).
Table 2 Distribution of pronominal anaphors in the
corpus
Pronominal Anaphors Num
Personal (it, they) 23
Reflexive (itself, themselves) 1
Relative (which, that) 113
Distributive (both each, either, neither 8
Demonstrative (these, this, those, that) 12
Indefinite (all, some, many, one) 8
Total Phrases: 165
Table 3 Distribution of nominal anaphors in the corpus.
Nominal Anaphors Num
Definite (the) 37
Possessive (its, theirs) 52
Distributive (both, each, either, neither) 11
Demonstrative (these, this, those, that) 58
Indefinite (other, another, all) 8
Total Phrases: 166
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pronouns consisting of units ‘both’, ‘either’, ‘neither’
from correlative expressions, a regular expression (see
Table 5) was developed.
Once a nominal candidate has been selected, it is
necessary to determine its grammatical number. Unfor-
tunately, MMTx does not provide this information, so
every phrase’s head noun was matched against a set of
lexical patterns (see Table 6) to decide its number.
Moreover, a regular expression is applied to detect
coordinative structures occurring inside a sentence. This
expression is helpful to resolve those anaphors matching
plural antecedents if they are expressed by mean of a
coordinative structures as shown in Table 7.
Determination of anaphora scope and antecedent selection
The range of searching for a possible antecedent is not
unlimited. As referred, this approach makes use of the
framework called ‘centering’ [19] to account for the way
information is structured and focused linguistically.
Entities (centers) referred to in an utterance serve to
link that utterance to others in the segment that con-
tains them. The main claims of this theory applied to
anaphora resolution are the following:
1. The choice of a center (antecedent) for a certain
anaphora is from the set of entities (centers) of the
previous utterance (locality).
2. Entities mentioned in an utterance are more cen-
tral than others according to this function
(subject>object>other).
3. Each anaphoric expression in an utterance has
exactly one antecedent (center).
In this approach, anaphoric expressions were asso-
ciated to just one antecedent (third claim). This antece-
dent is taken from the previous ordered sequence of
entities (centers) (first and second claims). Basically the
system tries to match an anaphoric expression against
candidates in the same sentence sorted by position from
left to right. The more central an entity is, the higher
the possibility it is to be located on the left side of a
sentence (subjects are usually at the beginning); in case
no antecedent matches, it moves backward up to the
previous sentence and searches for antecedents from left
to right again.
However, it was observed that the Centering Theory
cannot account for certain types of anaphoric expres-
sions whose antecedents are in most cases to be
found locally. Relative, reflexive and possessive ana-
phoric expressions find their antecedent in the pre-
vious context in most of the cases, so it was decided
not to apply Centering Theory on this kind of expres-
sions and link them to the closest nominal phrase
that satisfied their semantic and morphological
restrictions.
For each of the ordered list of candidates selected in
the previous phase, the system checks one by one
whether their linguistic features are consistent with fea-
tures of the anaphoric expression. Nominal phrases and
pronouns present number agreement with their antece-
dents. Nominal phrases in coordinative or appositive
relation were taken as the same center (antecedent).
Additionally, nominal phrase anaphors following center-
ing restrictions were determined to match nominal
phrases representing drugs, in particular those phrases
classified by MMTx according to one of the following
semantic types: pharmacological substances (phsu), anti-
biotics (antb) or clinical drug (clnd). Likewise, these
phrases must not be composed of abstract drugs (drug
families or phrases such as ‘the medicine’ or ‘this drug’),
but a drug specifically.
Results
As there is no previous work on anaphora resolution in
pharmacological texts, it was decided to develop an ad-
hoc baseline strategy for anaphora resolution that simply
selects the closest nominal phrase. The anaphoric
expressions considered are those referred to in
Table 4 Rules to recognize pleonastic-it expressions.
Rules Examples
IT [MODALVERB [NOT]?]? BE [NOT]? [AJD|ADV| VP]*
[THAT|WHETHER]
It is not known whether other progestational contraceptives are adequate methods of
contraception during acitretin therapy.
IT [MODALVERB [NOT]?]? BE [NOT]? ADJ [FOR np]
TO VP
If it is not possible to discontinue the diuretic, the starting dose of trandolapril should be
reduced.
IT [MODALVERB [NOT]]? [SEEM|APPEAR|MEAN|
FOLLOW] [THAT] *
It does not appear that the SSRIs reduce the effectiveness of a mood stabilizer in these
populations
Table 5 Regular expressions to detect correlative expressions.
Rule Example
[BOTH|EITHER|NEITHER] [N P|P P|U NK] [AND|
OR|NOR] [NP|PP|UNK]
These pharmacokinetic effects seen during diltiazem coadministration can result in increased clinical
effects (e.g., prolonged sod ation)of both midazolam and triazolam.
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sent approach, results of the anaphora resolver were
compared with those provided by the corpus. From the
331 anaphoric expressions considered, 265 were
detected by the system and 232 were successfully
attached to an antecedent. For testing system accuracy
an F-score measure with b = 1 ,a l s oc a l l e dab a l a n c e d
F-score, a weighted harmonic mean of precision and
recall were used. Global results of both baseline and
present approach are shown in Table 8. Results for the
different types of anaphora are shown in the tables 9
and 10.
The results obtained by DrugNerAR achieved an
increment of 73% respect to the baseline and the system
outperforms our previous approach for drug anaphora
resolution based on constraints and scoring [26]. This is
explicable since previous approach enphasized the proxi-
mity of the candidate to the anaphoric expression and
antecedents can be found at the beginning of the same
or previous sentence as it is pointed out by [19].
Regarding other approaches, our results are not directly
comparable to these works, but partially:
1. Syntax changes from a domain to another. Most
approaches in the biomedical domain deal with
documents from MedLine accounting for any bio-
medical topic, whereas our documents focus on drug
interactions. Subsequently, we consider that language
style of our documents must be linguistically
oriented to the reflection of such relations. Only
works [18] and [21] deal with documents accounting
for protein interactions.
2. Other works mostly address the anaphora resolu-
tion issue by using a set of morphosyntactic proper-
ties, so resolution is going to be determined by the
way that a document has been analyzed. For exam-
ple, expressions like these drugs or this medication
are required to be analyzed by a knowledge resource
that identifies and analyze them both syntactically
(they are nominal phrases in the subject, object or
other type of position in the sentence) and
semantically (they stand for drugs). Some approaches
make use of open-domain analyzers like [24] with
RASP. Conversely, other approaches makes use of
the corpus Genia that has been manually tagged and
it does not contain annotation errors (this has a defi-
n i t ei n f l u e n c eo v e rr e s u l t s ) .T h ed e g r e eo fp r e c i s i o n
in annotation is extremely important since results
depend on such results. Our system makes used of
MMTx, that although has shown to be useful for the
analysis of biomedical texts, has several syntactic and
semantic parsing errors.
To our opinion, from the list of approaches referred to
in the Background section [18] is the closest to ours. As
discussed, such an approach addresses the issue of ana-
phora resolution in the domain of protein interactions,
Table 6 Lexical patterns to determine grammatical
number.
Number Lexical pattern
Plural: [A-Z]+(S|IES|OES|XES|SHES|CHES|SES|ZES)
Exception for singular: [A-Z]+(U|S)S
Table 7 Rules to detect coordinative structures.
Rule Example
( [NP|PP|UNK],)* [NP|PP|UNK] [AND|OR|
NOR] [NP|PP|UNK]
While all the selective serotonin reuptake inhibitors ( SSRIs ) e.g. fluoxetine, sertraline and paroxetine
inhibit P450 2D6, they may vary in the extent of inhibition.
Table 8 Global results for the baseline and the approach.
Baseline Centering Approach
Total Precision Recall F-
baseline
Precision Recall F-
approach
Inc
331 0.49 0.40 0.44 0.84 0.7 0.76 0.73
Increment (Inc) is defined as follows Inc
FF
F
approach baseline
baseline


Table 9 Results for pronominal anaphora resolution.
Baseline Approach
Type Total P R F P R F Inc
Personal 23 0.26 0.26 0.26 0.91 1 0.95 2.65
Reflexive 1 1 1 1 1 1 1 0
Relative 120 0.83 0.81 0.82 1 0.99 0.99 0.21
Distributive 8 0.33 0.12 0.18 0.85 0.87 0.86 3.78
Demonstrative 11 0 0 0 0.33 0.27 0.29 ∞
Indefinite 8 0.25 0.12 0.16 0.57 0.62 0.59 2.69
Global results 164 0.67 0.65 0.66 0.92 0.904 0.91 0.38
Table 10 Results for nominal anaphora resolution.
Baseline Approach
Type Total P R F P R F Inc
Definite 37 0 0 0 0.54 0.59 0.56 TO
Possessive 52 0.53 0.42 0.47 0.76 1 0.86 0.83
Distributive 11 0.20 0.27 0.23 0.77 0.90 0.82 2.57
Demonstrative 58 0.03 0.01 0.02 0.81 0.48 0.60 29
Indefinite 8 0 0 0 0.40 0.37 0.38 to
Global results 166 0.23 0.15 0.18 0.71 0.47 0.56 2.11
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morphosyntactic complexity of this kind of documents
and resolution problems have been faced with an
approach that also used Centering Theory. As it can be
seen in Table 1, our work obtains similar results to [18]
for nominal phrase anaphora resolution and better
results for pronominal anaphora.
Conclusions
Compiling a comprehensive database of drug-drug inter-
actions is a relation extraction task that requires the
resolution of anaphoric expressions in biomedical and
pharmacological texts. It is believed that anaphora reso-
lution would improve the recall of any extraction
method and it would be particularly useful for semiauto-
mated compilation of drug-drug interactions.
The described approach for anaphora resolution uses
Centering Theory in order to select the scope of the
anaphoric expressions and assign the correct antecedent.
In contrast, a simple heuristic that selects the closer
nominal phrase has been experimentally useful in this
domain for some types of expressions, relative pronouns
and possessive nominal anaphors.
A key component of the approach is the use of several
domain resources, including the MMTx biomedical par-
ser and the UMLS meta-thesaurus. Other approaches
that have deal with biomedical documents have used
domain-independent parsers that do not adequately
handle the syntactic complexity of biomedical language,
including terminology. Unfortunately, MMTx only pro-
vides shallow syntactic information, so it can be
expected that full syntactic parsing improves the perfor-
mance of the linguistic rule-based analyzer. UMLS has
been useful in order to identify the anaphors and imple-
ment semantic restrictions to candidate resolution.
Future work will consider the overall contribution of
the anaphora resolution module in the broader task of
drug-drug interaction extraction and their evaluation on
a larger corpus. Although sources of interaction infor-
mation like Medline abstracts and DrugBank may share
a common literary style, the distribution of interactions
is very different and it also deserves investigation. More-
over, semantic information about drug families provided
by DrugNer can be valuable for the improvement in the
resolution of certain nominal anaphors. In the following
example, DrugNer could identify ‘venlafaxine’ like a
antidepressant drug, and this would help to correctly
resolve the anaphor ‘the antidepressant effect’,i nt h e
following sentence: Coadministration of naloxone with
venlafaxine did not modify the antidepressant effect.
Additional extensions of this work include the extend-
ing the coverage of the approach to other kinds of bio-
medical entities (such as genes, diseases or drug targets),
the increasing of the size of the corpus in order to make
more reliable conclusions, and the application of
machine learning techniques that have been successfully
applied on other domains.
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